Veradermics to Discuss Phase 3 VDPHL01 Trial Results
Veradermics will hold a conference call to discuss topline results from its Phase 3 ‘304’ clinical trial of VDPHL01 in males with mild-to-moderate pattern hair loss.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Veradermics to Discuss Phase 3 Trial Results on Investor Call
Veradermics plans to review topline results from its Phase 3 ‘304’ VDPHL01 trial in males with mild-to-moderate pattern hair loss on an investor call and webcast scheduled for October 19, 2026, at 8:00 a.m. ET.